Teladoc Health closed at $9.41 on Nov 5, down 2.99%, 3.2% below its 52-week closing high. Volume of 10.4M shares was 1.99× its 20-day average (above normal).
Split-adjusted performance: +69.2% over one month, +35.2% over six months, +17.9% over one year.
In the quarter ended Sep 30, 2026, revenue was $605.10M, down 3.4% from a year earlier, with a net margin of -4.5%.
Short interest was 32.1M shares at the Oct 15 settlement, up 6.5% from the prior report (17.8% of float, 8.2 days to cover).